← Back to Search

Behavioral Intervention

Resistance Training for Menopause

N/A
Waitlist Available
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
One year of no periods or categorized as menopause
Female at birth
Must not have
Unable to perform strength training movements
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 month
Awards & highlights
No Placebo-Only Group

Summary

"This trial aims to test whether a strength training program using resistance bands, and supported by experts, is feasible and acceptable for menopausal women who may face barriers to regular exercise. The goal is to

Who is the study for?
This trial is for women going through menopause who are interested in an at-home strength training program. Participants should be willing to train regularly and have no prior regular strength training routine. Specific eligibility details aren't provided, but typically participants must be healthy enough for physical activity.
What is being tested?
The study is testing a new home-based resistance training program designed specifically for menopausal women. It uses bands and expert guidance to help overcome common barriers like time constraints, safety concerns, and lack of knowledge about exercises.
What are the potential side effects?
Since this intervention involves physical exercise, potential side effects may include muscle soreness, fatigue, or injury if exercises are not performed correctly. Expert support aims to minimize these risks.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have not had a period for one year or am considered menopausal.
Select...
I was assigned female at birth.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I cannot do exercises that require lifting weights.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 month for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Liking of the intervention
number of strength exercises the participant logged over the intervention
Secondary study objectives
Change in number of full body weight squats in 60 seconds
Change in total seconds a participant can remain in a wall sit
Number of participants completing post 3 month measure / those randomized and consented

Side effects data

From 2010 Phase 2 trial • 167 Patients • NCT00112151
66%
Other noncardiovascular serious adverse events
13%
Other nonserious adverse events
11%
Persistently elevated PSA
4%
Total serious cardiovascular adverse events
4%
Persistently elevated HCT >= 54%
2%
Elevated AUA
100%
80%
60%
40%
20%
0%
Study treatment Arm
Placebo
Lower-range T
Higher-range T

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Single Session Resistance Training: Stronger SessionsExperimental Treatment1 Intervention
Home-based strength training exercises would be broken up into 3 weekly sessions throughout the week.
Group II: Shorter Resistance Training: Stronger SnacksExperimental Treatment1 Intervention
Home-based strength training exercises would be broken up into shorter segments throughout the day or week (e.g. a "snack" might be 3 sets of body-weight or band-based squats).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Resistance Training
2019
Completed Phase 2
~1230

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,484 Previous Clinical Trials
17,516,061 Total Patients Enrolled
~40 spots leftby Aug 2026